Trilaciclib

Trilaciclib is a member of piperazines and a member of pyridines. Trilaciclib is a Kinase Inhibitor. The mechanism of action of trilaciclib is as a Cyclin-dependent Kinase 4 Inhibitor, and Cyclin-dependent Kinase 6 Inhibitor, and Organic Cation Transporter 2 Inhibitor, and Multidrug and Toxin Extrusion Transporter 1 Inhibitor, and Multidrug and Toxin Extrusion Transporter 2 K Inhibitor. It is grouped under the following drug class(es): CDK4/6 Inhibitors. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include trilaciclibum and Cosela. Its PubChem CID is 68029831.

CAS No 1374743-00-6
Molecular Formula C24H30N8O
Molecular Weight 446.5 g/mol
Synonyms 4-[[5-(4-methylpiperazin-1-yl)pyridin-2-yl]amino]spiro[1,3,5,11-tetrazatricyclo[7.4.0.02,7]trideca-2,4,6,8-tetraene-13,1′-cyclohexane]-10-one

Frequently Asked Questions